Cornelis B.H.W. Lamers mostly deals with Internal medicine, Gastroenterology, Pathology, Endocrinology and Inflammatory bowel disease. His Internal medicine study frequently links to adjacent areas such as Surgery. Cornelis B.H.W. Lamers has included themes like Esophagitis, Chemotherapy and Esophageal disease in his Gastroenterology study.
His Pathology research is multidisciplinary, relying on both Cancer, Colorectal cancer, Metastasis and Matrix metalloproteinase. His Endocrinology research includes elements of Cholecystokinin and In vivo. His study in Inflammatory bowel disease is interdisciplinary in nature, drawing from both Intestinal mucosa, Inflammation, Immunology, Ulcerative colitis and Crohn's disease.
His main research concerns Internal medicine, Endocrinology, Gastroenterology, Cholecystokinin and Pathology. Pancreatic polypeptide, Stomach, Gastrin, Postprandial and Omeprazole are among the areas of Internal medicine where the researcher is concentrating his efforts. Cornelis B.H.W. Lamers has researched Omeprazole in several fields, including Esophagitis and Ranitidine.
The study incorporates disciplines such as Disease and Esophageal disease in addition to Gastroenterology. His Cholecystokinin research includes themes of Radioimmunoassay, Gastric emptying, Gallbladder and Antagonist. His research in Pathology intersects with topics in Plasminogen activator and Cancer, Colorectal cancer, Adenocarcinoma.
His primary areas of study are Internal medicine, Pathology, Gastroenterology, Matrix metalloproteinase and Cancer research. His Internal medicine research incorporates elements of Endocrinology and Oncology. The various areas that Cornelis B.H.W. Lamers examines in his Endocrinology study include Receptor and Pharmacodynamics.
His work in the fields of Pathology, such as Carcinoma and Myofibroblast, overlaps with other areas such as Vascular endothelial growth factor and Allogeneic transfusion. His Liver disease study, which is part of a larger body of work in Gastroenterology, is frequently linked to In patient, bridging the gap between disciplines. His studies in Cancer research integrate themes in fields like Colorectal cancer, Matrilysin, Metalloproteinase and Genotype.
Cornelis B.H.W. Lamers focuses on Pathology, Immunology, Matrix metalloproteinase, Inflammatory bowel disease and Cancer. His Pathology study frequently draws connections between related disciplines such as Gastroenterology. His Immunology research also works with subjects such as
His Inflammatory bowel disease study integrates concerns from other disciplines, such as Crohn's disease, Inflammation, Intestinal mucosa and Ulcerative colitis. His work carried out in the field of Cancer brings together such families of science as Immunohistochemistry, Cancer research and Cytokine. His Myeloperoxidase study is concerned with the field of Internal medicine as a whole.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Atrophic Gastritis and Helicobacter pylori Infection in Patients with Reflux Esophagitis Treated with Omeprazole or Fundoplication
E J Kuipers;L Lundell;E C Klinkenberg-Knol;N Havu.
The New England Journal of Medicine (1996)
A comparison of budesonide with prednisolone for active Crohn's disease
Paul Rutgeerts;R Löfberg;H Malchow;C Lamers.
The New England Journal of Medicine (1994)
Long-Term Treatment with Omeprazole for Refractory Reflux Esophagitis: Efficacy and Safety
Elly C. Klinkenberg-Knol;Henk P. M. Festen;Jan B. M. J. Jansen;Cornelis B. H. W. Lamers.
Annals of Internal Medicine (1994)
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Anders Walan;Jean-Pierre Bader;Meinhard Classen;Cornelis B.H.W. Lamers.
The New England Journal of Medicine (1989)
Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidants
Laurens Kruidenier;Ineke Kuiper;Cornelis B. H. W. Lamers;Hein W. Verspaget.
The Journal of Pathology (2003)
Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.
C.F.M. Sier;F.J.G.M. Kubben;S. Ganesh;M.M. Heerding.
British Journal of Cancer (1996)
Endoscopic regression of Barrett’s oesophagus during omeprazole treatment; a randomised double blind study
F T M Peters;S Ganesh;E J Kuipers;W J Sluiter.
Gut (1999)
Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients.
P. F. H. J. Quaedvlieg;O. Visser;C. B. H. W. Lamers;M. L. G. Janssen-Heijen.
Annals of Oncology (2001)
Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease
Laurens Kruidenier;Ineke Kuiper;Wim Van Duijn;Marij A C Mieremet-Ooms.
The Journal of Pathology (2003)
Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
Michael Fried;Urs Erlacher;Werner Schwizer;Christine Löchner.
Gastroenterology (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Maastricht University
Leiden University
Leiden University Medical Center
Leiden University Medical Center
Vrije Universiteit Amsterdam
Utrecht University
University Medical Center Groningen
Saint Louis University
Leiden University Medical Center
Erasmus University Rotterdam
Hong Kong University of Science and Technology
University of Lübeck
University of Tokyo
Osaka City University
National Renewable Energy Laboratory
Université Paris Cité
RWTH Aachen University
University of California, San Diego
Duke University
Leibniz Institute for Neurobiology
Cornell University
Loyola University Chicago
Universidade Federal do Ceará
McGill University
Mahidol University
Stanford University